Title : Synergistic induction of apoptosis in high-risk DLBCL by BCL2 inhibition with ABT-199 combined with pharmacologic loss of MCL1.

Pub. Date : 2015 Aug

PMID : 25882699






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Here we explore drugs that cause loss of MCL1, particularly the potent new cyclin-dependent kinase inhibitor dinaciclib, which knocks down MCL1 by inhibiting CDK9. dinaciclib cyclin dependent kinase 9 Homo sapiens